NASDAQ:CLBT
Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 2 opinions in the last 12 months.
Cellebrite (CLBT-Q) stands out as a leading provider of data analysis solutions for law enforcement and military agencies, leveraging AI technology to streamline the investigation of vast amounts of information, particularly from cell phone records. The company has demonstrated strong growth, supported by good profit margins and a solid cash reserve of $400 million, which enhances its financial stability. Analysts are optimistic about its future potential, noting that it operates in a niche market with a moderate competitive advantage or 'moat.' With a market capitalization of under $4 billion, Cellebrite is significantly smaller than its peers in the industry, positioning it as a potential acquisition target. Overall, the positive sentiment is reflected in the stock's 'Top Pick' designation, and analysts advocate for buying shares, setting a price target of $22.43.
It is very good at tracing data for the police, military and other agencies. One of the best use cases for AI is looking at data. This is so good for the overwhelming amount of info that police have to look at. CLBT scrubs the info to find clues and patterns and can find information quickly. It has $400 million in cash along with very good growth. With a market cap of less than $4 billion it is much smaller than other companies in the same field. The customer base gives confidence in the company. Buy 8 Hold 0 Sell 0
(Analysts’ price target is $22.43)Cellebrite is a American stock, trading under the symbol CLBT-Q on the NASDAQ (CLBT). It is usually referred to as NASDAQ:CLBT or CLBT-Q
In the last year, 3 stock analysts published opinions about CLBT-Q. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cellebrite.
Cellebrite was recommended as a Top Pick by on . Read the latest stock experts ratings for Cellebrite.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Cellebrite In the last year. It is a trending stock that is worth watching.
On 2025-07-03, Cellebrite (CLBT-Q) stock closed at a price of $15.45.
Its performance has been disappointing, and we do look at momentum of stocks (negative here). But we still think it is worth holding for mid-cap growth investors. It has $500M cash, and good earnings growth is expected still, and the sector outlook overall remains robust.
Unlock Premium - Try 5i Free